Parkinson disease (PD) is the most common neurodegenerative movement disorder. In
Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 …

A wide range of neurodegenerative diseases (NDs), including Alzheimer's disease,
Parkinson's disease, Huntington's disease, and prion diseases, share common mechanisms …

Neurological diseases are frequently associated with swallowing disorders and malnutrition.
Moreover, patients with neurological diseases are at increased risk of micronutrient …

Parkinson’s Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology,
Clinical Presentation, and Diagnosis - PMC Skip to main content Here's how you know …

Importance Parkinson disease is the second most common neurodegenerative disease
worldwide. Although no available therapies alter the underlying neurodegenerative process …

Parkinson's disease is a common movement disorder seen in neurological practice, but the
diagnosis and management is challenging. The diagnosis is clinical and sometimes difficult …

Background: Lack of a global consensus on the definition of advanced Parkinson's disease
(APD) and considerations for timing of device-aided therapies may result in heterogeneity in …

Background: Ever since the pioneering reports in the 60s, L-3, 4-Dioxyphenylalanine
(levodopa) has represented the gold standard for the treatment of Parkinson's Disease (PD) …

Objectives: This multicenter, double-blind, randomized controlled trial assessed the safety
and effectiveness of responsive cortical stimulation as an adjunctive therapy for partial onset …

Deep-Brain Stimulation for Parkinson's Disease | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH The New …